Teva refinances all-important 2021 stack.
Teva's turnaround is picking up momentum.
Teva is simply too cheap now.
***This article was first released to readers in my Marketplace service***
Teva (NYSE:TEVA) is the biggest generics manufacturer in the world. It makes strong free cash flow and is very cheaply